181 related articles for article (PubMed ID: 38236926)
1. Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center.
Schnitzler F; Tillack-Schreiber C; Szokodi D; Braun I; Tomelden J; Sohn M; Bader F; Waggershauser C; Ochsenkühn T
PLoS One; 2024; 19(1):e0290887. PubMed ID: 38236926
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection.
Mitsuya JB; Gonzalez R; Thomas R; El-Baba M
J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):334-338. PubMed ID: 30247424
[TBL] [Abstract][Full Text] [Related]
3. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
Cai Q; Ding Z; Fu AZ; Patel AA
BMC Gastroenterol; 2022 Dec; 22(1):545. PubMed ID: 36581802
[TBL] [Abstract][Full Text] [Related]
4. Beyond diagnosis: investigating hospital referral impact on biological treatment initiation, hospital admission, and surgery patterns in inflammatory bowel disease - a Danish population based study.
Larsen L; Olesen AE; Nayeb AB; Grøntved S; Krarup AL
Scand J Gastroenterol; 2024 Jun; 59(6):690-697. PubMed ID: 38567864
[TBL] [Abstract][Full Text] [Related]
5. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study.
Khoudari G; Mansoor E; Click B; Alkhayyat M; Saleh MA; Sinh P; Katz J; Cooper GS; Regueiro M
Clin Gastroenterol Hepatol; 2022 May; 20(5):e974-e983. PubMed ID: 33065311
[TBL] [Abstract][Full Text] [Related]
6. Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: A nationwide administrative database analysis.
Yoshida S; Imai S; Fushimi K
J Gastroenterol Hepatol; 2024 Feb; 39(2):272-279. PubMed ID: 37961024
[TBL] [Abstract][Full Text] [Related]
7. Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients.
Kim GH; Kim M; Kim K; Park JB; Baek JE; Bae JH; Hong SW; Hwang SW; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
Yonsei Med J; 2024 May; 65(5):276-282. PubMed ID: 38653566
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.
Choi YI; Kim TJ; Park DK; Chung JW; Kim KO; Kwon KA; Kim YJ
Int J Colorectal Dis; 2019 Oct; 34(10):1713-1721. PubMed ID: 31471699
[TBL] [Abstract][Full Text] [Related]
9. Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.
Hirayama D; Hyodo S; Morita K; Nakase H
J Gastroenterol; 2024 May; 59(5):389-401. PubMed ID: 38492011
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of postoperative fentanyl consumption in patients with inflammatory bowel disease: a retrospective cohort study.
Tsuboi S; Kubota K; Mihara T; Taguri M; Inagawa G; Goto T
BMC Anesthesiol; 2022 Mar; 22(1):70. PubMed ID: 35277136
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O
J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388
[TBL] [Abstract][Full Text] [Related]
12. Biologics in Pediatric Inflammatory Bowel Disease.
Kleinhenz J; Wagner E
Pediatr Ann; 2022 Feb; 51(2):e77-e81. PubMed ID: 35156888
[TBL] [Abstract][Full Text] [Related]
13. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
Lightner AL; Grass F; Alsughayer AM; Harmsen WS; Petersen M; Loftus EV
Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787
[TBL] [Abstract][Full Text] [Related]
14. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
15. The need for surgery in pediatric patients with inflammatory bowel disease treated with biologicals.
Kolho KL; Nikkonen A; Merras-Salmio L; Molander P
Int J Colorectal Dis; 2024 Apr; 39(1):58. PubMed ID: 38661931
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
[TBL] [Abstract][Full Text] [Related]
17. Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Jung YS; Han M; Park S; Cheon JH
Dig Dis Sci; 2020 May; 65(5):1436-1444. PubMed ID: 31677070
[TBL] [Abstract][Full Text] [Related]
18. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review.
Byrne LW; McKay D
Surgeon; 2021 Oct; 19(5):e153-e167. PubMed ID: 34581275
[TBL] [Abstract][Full Text] [Related]
19. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
[TBL] [Abstract][Full Text] [Related]
20. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
